West Michigan Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.27M Sell
16,983
-49
-0.3% -$10.5K 0.81% 39
2026
Q1
$3.7M Sell
17,032
-214
-1% -$47.5K 0.81% 34
2025
Q4
$3.94M Sell
17,246
-479
-3% -$109K 0.9% 20
2025
Q3
$4.1M Sell
17,725
-5,279
-23% -$1.08M 0.99% 16
2025
Q2
$4.27M Buy
23,004
+14,712
+177% +$2.73M 1.2% 20
2025
Q1
$1.74M Sell
8,292
-14
-0.2% -$2.72K 0.58% 45
2024
Q4
$1.48M Sell
8,306
-738
-8% -$136K 0.45% 49
2024
Q3
$1.79M Sell
9,044
-984
-10% -$184K 0.54% 45
2024
Q2
$1.72M Buy
10,028
+87
+0.9% +$14.4K 0.55% 42
2024
Q1
$1.81M Buy
9,941
+411
+4% +$70.8K 0.59% 43
2023
Q4
$1.48M Buy
9,530
+147
+2% +$21.4K 0.56% 43
2023
Q3
$1.4M Buy
9,383
+115
+1% +$16.9K 0.75% 39
2023
Q2
$1.25M Sell
9,268
-615
-6% -$90.2K 0.5% 57
2023
Q1
$1.58M Buy
9,883
+4,822
+95% +$737K 0.89% 28
2022
Q4
$818K Sell
5,061
-73
-1% -$11.2K 0.6% 37
2022
Q3
$690K Buy
5,134
+84
+2% +$12.1K 0.6% 41
2022
Q2
$773K Buy
5,050
+4
+0.1% +$611 0.66% 41
2022
Q1
$818K Buy
5,046
+712
+16% +$103K 0.55% 40
2021
Q4
$587K Buy
+4,334
New +$512K 0.44% 52

Other funds holding ABBV

West Michigan Advisors's ABBV Position: Q2 2026 in Review

West Michigan Advisors reduced its AbbVie (ABBV) stake by 0.29% in Q2 2026, selling an estimated $10.5K and leaving 16,983 shares worth $4.27M. The position accounts for 0.81% of the portfolio, ranked #39.

West Michigan Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • West Michigan Advisors held 16,983 shares of AbbVie worth $4.27M as of Q2 2026.
  • West Michigan Advisors sold 49 AbbVie shares in Q2 2026, an estimated $10.5K.
  • AbbVie made up 0.81% of West Michigan Advisors's portfolio in Q2 2026, its #39 holding.
  • West Michigan Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.